Morgan Stanley Maintains Overweight on ArcBest, Raises Price Target to $145

ArcBest Corporation -0.04% Post

ArcBest Corporation

ARCB

138.80

138.80

-0.04%

0.00% Post

Morgan Stanley analyst Ravi Shanker maintains ArcBest (NASDAQ: ARCB) with a Overweight and raises the price target from $135 to $145.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via